Previous Page  33 / 44 Next Page
Information
Show Menu
Previous Page 33 / 44 Next Page
Page Background

33

21.Moser G. Should we incorporate psychological care into the management of IBD? Nat Clin Pract Gastroenterol Hepatol. 2006;

3: 416–17.

22.Mussell M, Böcker U, Nagel N, et al. Predictors of disease-related concerns and other aspects of health-related quality of life

in outpatients with inflammatory bowel disease. Eur J Gastroenterol Hepatol. 2004; 16: 1273–80.

23.Janke K-H, Klump B, Gregor M, et al. Determinants of life satisfaction in inflammatory bowel disease. Inflamm. Bowel Dis.

2005; 11: 272–86.

24.Casellas F, Barreiro de Acosta M, Iglesias M, Robles V, Nos P, Aguas M et al. Mucosal healing restores normal health and

quality of life in patients with inflammatory bowel disease. Eur J Gastroenterol Hepatol. 2012 Jul; 24(7): 762-9.

25.Carver CS, Scheier MF, Weintraub JK. Assessing coping strategies: a theoretically based approach. J Pers Soc Psychol. 1989;

56: 267-83.

26.Crespo ML, Cruzado JR. La evaluación del afrontamiento: adaptación Española del cuestionario COPE con una muestra de

estudiantes universitarios. Análisis y Modificación de Conducta. 1997; 23: 797–830.

27.Carver CS. You want to measure coping but your protocol’s too long: Consider the Brief COPE. International Journal of

Behavioral Medicine. 1997; 4(1): 92-100.

28.Casati J, Toner BB, de Rooy EC, et al. Concerns of patients with inflammatory bowel disease: a review of emerging themes.

Dig. Dis. Sci. 2000; 45: 26–31.

29.Kiebles JL, Doerfler B, Keefer L. Preliminary evidence supporting a framework of psychological adjustment to inflammatory

bowel disease. Inflamm. Bowel Dis. 2010; 16: 1685–95.

30.Scott KM, Bruffaerts R, Tsang A, et al. Depression-anxiety relationships with chronic physical conditions: results from the

World Mental Health Surveys. J Affect Disord. 2007; 103: 113–20.

31.Iglesias M, Barreiro de Acosta M, Vázquez I, Figueiras A, Nieto L, Lorenzo A et al. Psychological impact of Crohn’s disease on

patients in remission: anxiety and depression risks. Rev Esp Enferm Dig. 2009 Apr;101(4):249-57.

32.Van Assche G, Dignass A, Bokemeyer B, Danese S, Gionchetti P, Moser G et al. Second European evidence-based consensus on

the diagnosis and management of ulcerative colitis part 3: special situations. J Crohns Colitis. 2013 Feb; 7(1): 1-33.

33.Van Assche G, Dignass A, Reinisch W, van der Woude CJ, Sturm A, De Vos M et al. The second European evidence-based

Consensus on the diagnosis and management of Crohn’s disease: Special situations. J Crohns Colitis. 2010 Feb; 4(1): 63-101.

34.Mikocka-Walus AA, Turnbull DA, Moulding NT, et al. Controversies surrounding the comorbidity of depression and anxiety in

inflammatory bowel disease patients: a literature review. Inflamm. Bowel Dis. 2007; 13: 225–34.

35.Leue C, van Os J, Neeleman J, et al. Bidirectional associations between depression/anxiety and bowel disease in a population

based cohort. J Epidemiol Community Health. 2005; 59: 434.

36.Kessler RC, Ormel J, Demler O, et al. Comorbid mental disorders account for the role impairment of commonly occurring

chronic physical disorders: results from the National Comorbidity Survey. J. Occup. Environ. Med. 2003; 45: 1257–66.

37.Walker JR, Ediger JP, Graff LA, et al. The Manitoba IBD cohort study: a population-based study of the prevalence of lifetime

and 12-month anxiety and mood disorders. Am. J. Gastroenterol. 2008; 103: 1989–97.

38.Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. J Health Soc Behav. 1983; 24: 385-96.

39.Remor ECJ. Versión Española de la escala de estrés percibido (PSS-14): Estudio psicométrico en una muestra de VIH+. Ansiedad

y Estrés. 2001; 7: 195-201.

40.Remor E. Psychometric properties of a European Spanish version of the Perceived Stress Scale (PSS). Span J Psychol. 2006; 9:

86-93.

41.North CS, Alpers DH, Helzer JE, et al. Do life events or depression exacerbate inflammatory bowel disease? A prospective

study. Ann. Intern. Med. 1991; 114: 381–86.

revisión monográfica